News

Riddhi Siddhi Gluco Biols Ltd share price ticked higher by 1.53% to Rs 764.1 after the company`s net profit tanked by 109.19% to Rs 3.01 crore, while revenue from operations increased sharply by 893.04% to Rs 89.87 crore in Q2FY26 over Q1FY26. The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 49691.37 crore, improving 13.39%. It has eased by 1.11% over last one week and spiked sharply by 24.51% in last one month while the market capitalization of Riddhi Siddhi Gluco Biols Ltd has slipped by 2.04% and 12.87% in the same period respectively. Profit before tax (PBT) of Riddhi Siddhi Gluco Biols Ltd stood at Rs 4.99 crore in Q2 FY26, tumbling by 63.23% year-on-year, and crashing by 115.91% quarter-on-quarter. EBITDA came in at Rs 20 crore, declining 8.31% YoY and gaining 3.10% sequentially. Total expenses witnessed a sharp rise of 395.20% to Rs 94.83 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 6.38 crore, surging by 34.60% YoY, while employee benefits expense was at Rs 2.35 crore, soaring 12.98% YoY. For the TTM ended FY26, revenue from operations plunged by 49.43% to Rs 135.51 crore, while net profit improved by 10.25% to Rs 63.05 crore, compared to previous TTM. EBITDA saw a sharp decline of 8078% to Rs 85.78 crore, and PBT improved 10.46% to Rs 71.48 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 28.3 crore in FY26, as against Rs 8.91 crore in FY25. Riddhi Siddhi Gluco Biols Ltd rallied 46.83% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.

Riddhi Siddhi Gluco Biols announced that the Board of Directors of the Company at its meeting held on 25 May 2026, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.

Net loss of Riddhi Siddhi Gluco Biols reported to Rs 32.54 crore in the quarter ended March 2026 as against net profit of Rs 3.63 crore during the previous quarter ended March 2025. Sales declined 67.70% to Rs 9.05 crore in the quarter ended March 2026 as against Rs 28.02 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 12.71 crore in the year ended March 2026 as against net profit of Rs 5.20 crore during the previous year ended March 2025. Sales rose 74.04% to Rs 235.84 crore in the year ended March 2026 as against Rs 135.51 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales9.0528.02 -68 235.84135.51 74 OPM %-89.06-12.31 --5.211.47 - PBDT-1.5420.13 PL 38.7780.01 -52 PBT-3.5817.99 PL 30.5471.48 -57 NP-32.543.63 PL -12.715.20 PL Powered by Capital Market - Live News

Riddhi Siddhi Gluco Biols will hold a meeting of the Board of Directors of the Company on 19 May 2026.

Net Loss of Riddhi Siddhi Gluco Biols reported to Rs 1.59 crore in the quarter ended December 2025 as against net loss of Rs 36.05 crore during the previous quarter ended December 2024. Sales declined 9.59% to Rs 40.08 crore in the quarter ended December 2025 as against Rs 44.33 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales40.0844.33 -10 OPM %-13.77-1.71 - PBDT4.5816.95 -73 PBT2.5014.80 -83 NP-1.59-36.05 96 Powered by Capital Market - Live News